endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB with regimens containing bedaquiline or delamanid

Principal investigator

Locations

Armenia, Bangladesh, Belarus, Ethiopia, Georgia, Indonesia, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Myanmar, Nepal, Pakistan, Peru, South Africa
Topic

Tuberculosis
Methodology

Observational study
Reference

OCA020-27
Views

84
Downloaded

1

Purpose of study

To describe patient outcomes and assess factors associated with unfavorable outcomes (treatment failure, lost to follow-up and death). To estimate the frequency of adverse events of clinical significance.

Study status

Concept
Protocol & ERB
Implementation
Completion
Archived

Study timeline

Documents

PROTOCOL_ObservationalStudyOutput1_2016Jul20_v3.pdf 343 KB

Publications

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort

Hewison, Catherine "–" Oxford University Press (OUP) "(2022)"
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study

Franke, Molly F. "–" American Thoracic Society "(2021)"

Previous study

Next study